Clinical Trial Update: Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

View source ↗

Summary

Post-approval registry study for Corox OTW endocardial left ventricular steroid lead in patients with congestive heart failure has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Corox OTW Endocardial Left Ventricular Steroid Lead Bipolar

Snippet

Sponsor: Biotronik, Inc. | Conditions: Congestive Heart Failure | Status: COMPLETED | Results posted: 2019-11-29